rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Aspire-Lakewood Holdings, Inc.

ASBP · Nasdaq

Health CareBiotechnologyNot moving yet

ASBP stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 12.7% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
18% -14 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
13 (-1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

21 Apr – 20 Oct
18%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$15KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders13-1 on the quarter
New · exited3 · 4
Reported value$251K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
JANE STREET GROUP, LLCnew · filed 14 Aug 202614,830$79K+14,830
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202610,474$56K-32,910−75.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202610,408$56K+2,549+32.4%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 202610,081$54K+7,225+253.0%
Crewe Advisors LLCreduced · filed 24 Jul 2026677$3,616-19,658−96.7%
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026283$1,511-1,891−87.0%
TORONTO DOMINION BANKreduced · filed 14 Aug 2026166$886-4,834−96.7%
VALLEY WEALTH MANAGERS, INC.reduced · filed 4 Aug 202633$176-967−96.7%
Crossingbridge Advisors, LLCreduced · filed 13 Aug 202620$107-24,328−99.9%
MERCER GLOBAL ADVISORS INCnew · filed 11 Aug 20263$16+3
31 Mar 2025 – 30 Jun 2026
142127Mar 25Jun 25Dec 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Donald G. Fell Company insiderDirector · last 5 Jun 20254 · 0
Powerup Sponsor Llc Company insider10% owner · last 18 Aug 20230 · 1

Same industry

MRNA ModernaLeading+167%
IOVA Iovance BiotherapeuticsLeading+141%
ABCL AbCellera BiologicsLeading+57%
ENTX Entera BioLeading+52%
HALO Halozyme TherapeuticsLeading+48%
XERS Xeris Biopharma HoldingsLeading+47%
XNCR XencorLeading+41%
HELP Helus PharmaLeading+39%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 2025-1.9%
Share count trendFY 2025 · to 27 Mar 202642.2%
Cash and equivalentsFY 2025 · to 31 Dec 2025$1.0M

Analyst forecasts

No analyst forecasts yet.